Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.
| Brand name | SERTRALINE HYDROCHLORIDE |
| Generic name | SERTRALINE HYDROCHLORIDE |
| Active ingredient(s) | SERTRALINE HYDROCHLORIDE |
| Distributed by / for | Wal-Mart, Bentonville, AR 72716, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, Packaged by: Legacy Pharmaceutical Packaging LLC., Earth City, MO 63045 |
| NDC | 68645-523-54 |
| Full product label | Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, Packaged by: Legacy Pharmaceutical Packaging LLC., Earth City, MO 63045, NDC# 68645-523-54 |
| Recalling firm | Legacy Pharmaceutical Packaging LLC |
| Distribution | CA and AR |
| Quantity | 161,664 bottles |
| Recall initiated | 2023-12-11 |
| Report date | 2024-01-03 |
| Recall completed | — |
| Recall number | D-0205-2024 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Earth City MO United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗